'Final study report' diaporamas de présentation

Introduction

1.12k views • 89 slides

Initiatives to Combat Prescription Drug Abuse in Kentucky: a n Update on KASPER

Initiatives to Combat Prescription Drug Abuse in Kentucky: a n Update on KASPER. David R. Hopkins KASPER Program Manager Office of Inspector General Kentucky Cabinet for Health and Family Services The Different Faces of Substance Abuse January 28, 2014. Contents. Pill Mills

871 views • 73 slides

ESAs in Oncology and Management of Risks

ESAs in Oncology and Management of Risks. Vinni Juneja, MD Division of Biologic Oncology Products. Oncologic Drugs Advisory Committee March 13, 2008. Review Team. Chaohong Fan Patricia Keegan Mark Rothmann Yuan Li Shen Kyung Lee Monica Hughes. Outline. Background Regulatory History

861 views • 70 slides

Turkey: How to select a CRO and establish a long-term relationship?

719 views • 19 slides

LYMErix ? Lyme Disease Vaccine (Recombinant Osp A)

LYMErix ? Lyme Disease Vaccine (Recombinant Osp A). Center for Biologics Evaluation and Research May 21, 2002. LYMErix ?. Voluntary withdrawal of sale Distribution discontinued February 2002 Announced February 2002 GSK cited poor sales. LYMErix ?. (Voluntary withdrawal of sale cont.)

232 views • 14 slides

Spaceport and Range Technology Development Initiative Al Sofge NASA H

Spaceport and Range Technology Development Initiative Al Sofge NASA Headquarters May 15, 2001 Background-White House Led Range Study

453 views • 13 slides